Sanofi to acquire Belgian biotech firm Ablynx for €3.9bn in all-cash deal

French pharmaceutical giant Sanofi has successfully finalized an agreement to acquire Ablynx, a Belgian biotechnology firm, for approximately €3.9 billion. This strategic acquisition surpasses a ... Read More